Editorial: Evaluating the Prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients With Type 2 Diabetes and Hyperferritinemia

被引：1
|
作者：
Bhardwaj, Nakul J. [1 ]
Kim, Rebecca G. [1 ]
机构：
[1] Univ Utah Hlth, Dept Internal Med, Div Gastroenterol Hepatol & Nutr, Salt Lake City, UT 84132 USA
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2025年 / 61卷 / 04期
关键词：
D O I：
10.1111/apt.18453
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：727 / 728
页数：2
相关论文
共 50 条
  • [1] Editorial: Evaluating the Prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients With Type 2 Diabetes and Hyperferritinaemia-Authors' Reply
    Amangurbanova, Maral
    Loomba, Rohit
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025, 61 (04) : 729 - 730
  • [2] Metabolic dysfunction-associated steatotic liver disease prevalence and predictors in patients with type 2 diabetes in primary care
    Balkhed, Wile
    Nasr, Patrik
    Cai, Shan
    Simonsson, Christian
    Forsgren, Mikael
    Bergram, Martin
    Leinhard, Olof Dahlqvist
    Dahlstrom, Nils
    Carlhall, Carl-Johan
    Lundberg, Peter
    Radholm, Karin
    Iredahl, Fredrik
    Kechagias, Stergios
    Ekstedt, Mattias
    JOURNAL OF HEPATOLOGY, 2024, 80 : S532 - S532
  • [3] Implementing metabolic dysfunction-associated steatotic liver disease guidelines in patients with type 2 diabetes
    Ciardullo, Stefano
    Perseghin, Gianluca
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2025, 10 (02): : 97 - 98
  • [4] Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease
    Stefan, Norbert
    Roden, Michael
    DIABETOLOGIE UND STOFFWECHSEL, 2024, 19 : S290 - S296
  • [5] Prevalence and predictive features of metabolic dysfunction-associated steatotic liver disease in type 1 diabetes
    Snethlage, Coco M. Fuhri
    Meijnikman, Abraham S.
    Mak, Anne Linde
    Rampanelli, Elena
    Voermans, Bas
    Callender, Cengiz A. K.
    de Groen, Pleun
    Roep, Bart O.
    van Raalte, Daniel H.
    Knop, Filip K.
    Holleboom, Adriaan G.
    Nieuwdorp, Max
    Hanssen, Nordin M. J.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2024, 190 (05) : 391 - 400
  • [6] Metabolic dysfunction-associated steatotic liver disease-associated fibrosis and cardiac dysfunction in patients with type 2 diabetes
    Cernea, Simona
    Onisor, Danusia
    Roiban, Andrada Larisa
    Benedek, Theodora
    Rat, Nora
    WORLD JOURNAL OF CARDIOLOGY, 2024, 16 (10):
  • [7] Metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: risk of heart failure
    Oh, Rosa
    Kim, Gyuri
    Lee, Kyu-na
    Cho, So Hyun
    Kim, Ji Yoon
    Kim, Seohyun
    Lee, You-Bin
    Jin, Sang-Man
    Hur, Kyu Yeon
    Han, Kyungdo
    Kim, Jae Hyeon
    CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)
  • [8] Oral insulin therapy for metabolic dysfunction-associated steatotic liver disease in type 2 diabetes
    Kahl, S.
    DIABETOLOGIE, 2024, : 902 - 903
  • [9] The Influence of Coffee on Reducing Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients With Type 2 Diabetes: A Review
    Kaur, Manpreet
    Murugesan, Shanmathi
    Singh, Sachpreet
    Uy, Katherine N.
    Kaur, Jasjeet
    Mann, Navina
    Sekhon, Rajneet K.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (12)
  • [10] Association between metabolic dysfunction-associated steatotic liver disease and ischemic stroke in patients with type 2 diabetes
    Jang, M.
    Kim, G.
    Lee, K. -N.
    Han, K.
    Oh, R.
    Cho, S.
    Kim, J.
    Lee, Y. -B.
    Jin, S. -M.
    Hur, K.
    Kim, J.
    DIABETOLOGIA, 2024, 67 : S98 - S98
12345